Medical Research
Dana Farber Mass General Brigham Cancer Care Inc
BOSTON, MA
Total revenue
$137.6M
Total expenses
$137.0M
Net assets
$1.2M
Grants received
$6.0M
34 grants
EIN
043320640
Tax year
2023
Mission
Coordination of oncology clinical research, education and programs across dana-farber, massachusetts general hospital and brigham and women's hospital.
Financials
FY 2023
Revenue
Expenses
People
12 listed
David P Ryan MD
Trustee & President
—
1 hrs/wk
Benjamin Ebert MD PhD
Trustee (AS OF 4/15/24)
—
1 hrs/wk
Bruce Johnson MD
Trustee (END 4/15/24)
—
1 hrs/wk
BRUCE LEVY
TRUSTEE (AS OF 4/15/24)
—
1 hrs/wk
Jeffrey Meyerhardt MD MPH
Trustee
—
1 hrs/wk
Joseph Loscalzo MD PHD
Trustee (END 4/15/24)
—
1 hrs/wk
Paul Anderson MD PHD
TRUSTEE
—
1 hrs/wk
RAMESH A SHIVDASANI MD
TRUSTEE
—
1 hrs/wk
Effie Chan
Clerk
—
1 hrs/wk
Sally Mason Boemer
Treasurer
—
1 hrs/wk
Hillary Mankin-Kufe ESQ
FORMER CLERK
—
1 hrs/wk
Laurie H Glimcher MD
FORMER OFFICER
—
0Independent contractors
Dana-Farber Cancer Institute Inc
Research Services
MASS GENERAL BRIGHAM INC
Research Services
BETH ISRAEL DEACONESS MEDICAL CENTER
Research Services
BRIGHAM AND WOMEN'S HOSPITAL
Research Services
MEMORIAL SLOAN KETTERING CANCER CENTER
Research Services
Grants received
Showing 34 of 34
Funded by
$6.0M from 16 funders · 34 grants · 2017–2024
$3M · 1 grant · 2023
$1.5M · 1 grant · 2023
$902K · 4 grants · 2020–2024
$395K · 5 grants · 2019–2023
$107K · 3 grants · 2017–2019
$50K · 1 grant · 2023
$14K · 3 grants · 2021–2023
$8K · 1 grant · 2024